SCM
MURA

Solas Capital Management’s Mural Oncology MURA Stock Holding History

Solas Capital Management’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-887,995
Closed -$1.12M – 23
2025
Q1 		$1.12M Sell
887,995
-381,005
-30% -$1.39M 0.63% 20
2024
Q4 		$4.09M Hold
1,269,000
– – 2.71% 13
2024
Q3 		$3.97M Hold
1,269,000
– – 2.79% 13
2024
Q2 		$3.98M Buy
1,269,000
+520,039
+69% +$1.92M 2.18% 16
2024
Q1 		$3.66M Buy
+748,961
New +$3.64M 2.36% 15

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Solas Capital Management's MURA Position: Q2 2025 in Review

Solas Capital Management sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 887,995 shares — an estimated $1.12M sold.

Solas Capital Management first reported a position in MURA in Q1 2024 and held it in 5 quarters. The position peaked at $4.09M in Q4 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Solas Capital Management reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Solas Capital Management sold 887,995 Mural Oncology shares in Q2 2025, an estimated $1.12M.
  • Solas Capital Management first reported a position in Mural Oncology in Q1 2024 and held it in 5 quarters.
  • Solas Capital Management's Mural Oncology position peaked at $4.09M in Q4 2024.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Solas Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.